Immix Biopharma, Inc. (IMMX) Prices $125M Stock Offering at $11

Immix Biopharma priced an underwritten offering of 11,363,637 common shares at $11.00 per share for gross proceeds of $125M, expected to close on or about Sept. 30, 2026, subject to customary conditions.Material DetailsContext by AI AnalystThis is a capital raise to fund ongoing development of NXC…